Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-02

Clinical Trial Update: Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)

View source ↗

Summary

Pfizer's Zyvox (linezolid) was studied in a special investigation trial for vancomycin-resistant Enterococcus faecium; the trial is completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYVOX (LINEZOLID)

Snippet

Sponsor: Pfizer | Conditions: Vancomycin Resistance Enterococcus Faecium | Status: COMPLETED | Results posted: 2012-07-02